Overview

Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are: - To evaluate the safety and tolerability of single and multiple oral doses of CJ-12420 in healthy male subjects. - To evaluate the single- and multiple-dose PK of orally administered CJ-12420 in healthy male subjects. - To evaluate the single- and multiple-dose PD of orally administered CJ-12420 in healthy male subjects. - To compare the multiple-dose pharmacodynamics (PD) of orally administered CJ-12420 and esomeprazole in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
CJ HealthCare Corporation
HK inno.N Corporation
Treatments:
Esomeprazole